Nature Cancer

Medications

Locking leukemia's cellular escape hatch

Leukemia starts in cells that would normally develop into different types of blood cells. About 61,000 people in the U.S. are diagnosed each year, and depending on the type of leukemia and the age of the patient, five-year ...

Oncology & Cancer

Immune cell linked to better lung cancer survival

Around 48,500 people are diagnosed with lung cancer in the UK each year. New treatments are desperately needed as fewer than 20% of patients survive for five years after diagnosis, and it is the biggest cause of death from ...

Oncology & Cancer

Reprogrammed macrophages promote spread of breast cancer

Metastatic breast cancer cells abuse macrophages, a type of immune cell, to promote the settlement of cancer metastases in the lungs. The reprogrammed macrophages stimulate blood vessel cells to secrete a cocktail of metastasis-promoting ...

page 8 from 16